Cardama Alfonso Quintas
Chief Medical Officer at TCR2 THERAPEUTICS INC.
- Sold, on record
- $40k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Dec 13, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TCR2 THERAPEUTICS INC.Chief Medical Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale TCR2 THERAPEUTICS INC.Plan not statedDec 2 2022
Sold 3,636 shares at $1.39 ($5k)
Cardama Alfonso Quintas, Chief Medical Officer
Sold 2.6% of holdings ($198k position)138,664 shares leftFirst sale on recordFiling
- 2 Form 4 sale TCR2 THERAPEUTICS INC.Plan not statedDec 6 +4 days
Sold 7,464 shares at $1.35 ($10k)
Cardama Alfonso Quintas, Chief Medical Officer
Sold 5.4% of holdings ($187k position)131,200 shares leftFiling
- 3 Form 4 sale TCR2 THERAPEUTICS INC.Plan not statedDec 8 +2 days
Sold 7,942 shares at $1.27 ($10k)
Cardama Alfonso Quintas, Chief Medical Officer
Sold 6.1% of holdings ($167k position)123,258 shares leftFiling
- 4 Form 4 sale TCR2 THERAPEUTICS INC.Plan not statedDec 13 +5 days
Sold 13,799 shares at $1.10 ($15k)
Cardama Alfonso Quintas, Chief Medical Officer
Sold 11.2% of holdings ($135k position)109,459 shares left1.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2022 | TCR2 THERAPEUTICS INC. | Chief Medical Officer | Form 4 sale | 13,799 | $15k | 11.2% | Plan not stated | SEC |
| Dec 8, 2022 | TCR2 THERAPEUTICS INC. | Chief Medical Officer | Form 4 sale | 7,942 | $10k | 6.1% | Plan not stated | SEC |
| Dec 6, 2022 | TCR2 THERAPEUTICS INC. | Chief Medical Officer | Form 4 sale | 7,464 | $10k | 5.4% | Plan not stated | SEC |
| Dec 2, 2022 | TCR2 THERAPEUTICS INC. | Chief Medical Officer | Form 4 sale | 3,636 | $5k | 2.6% | Plan not stated | SEC |